# Evaluation of Raltegravir During the Third Trimester of Pregnancy

> **NCT02099474** · PHASE2 · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 83 (actual)

## Conditions studied

- HIV-1 Infection
- PREGNANCY

## Interventions

- **OTHER:** Study of pharmacokinetic properties of raltegravir during the 3rd trimester of pregnancy

## Key facts

- **NCT ID:** NCT02099474
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-30
- **Primary completion:** 2017-01
- **Final completion:** 2017-04
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099474, "Evaluation of Raltegravir During the Third Trimester of Pregnancy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02099474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*